C36 ASTHMA THERAPY II: Exploration Of Exhaled Nitric Oxide (eno) Levels Following Treatment With Fluticasone Propionate (fp)/salmeterol Xinafoate (sx) Combination Inhaled Product To Demonstrate Pharmacodynamic (pd) Fp Bioequivalence (be)

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2015-01, Vol.191, p.1
Main Authors: Weiler, J M, Sorkness, C A, Hendeles, L, Zhu, Y, Nichols, S
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1073-449X
1535-4970